165 related articles for article (PubMed ID: 32353536)
1. Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
Khurana RN; Hill L; Ghanekar A; Gune S
Ophthalmol Retina; 2020 Nov; 4(11):1054-1058. PubMed ID: 32353536
[TBL] [Abstract][Full Text] [Related]
2. Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.
Abdelfattah NS; Hariri AH; Al-Sheikh M; Pitetta S; Ebraheem A; Wykoff CC; Sadda SR;
Am J Ophthalmol; 2018 Aug; 192():84-90. PubMed ID: 29763612
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography.
Wilde C; Patel M; Lakshmanan A; Amankwah R; Dhar-Munshi S; Amoaku W;
Eye (Lond); 2015 May; 29(5):602-9; quiz 610. PubMed ID: 25907206
[TBL] [Abstract][Full Text] [Related]
4. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
[TBL] [Abstract][Full Text] [Related]
5. Agreement of time-domain and spectral-domain optical coherence tomography with fluorescein leakage from choroidal neovascularization.
Khurana RN; Dupas B; Bressler NM
Ophthalmology; 2010 Jul; 117(7):1376-80. PubMed ID: 20452027
[TBL] [Abstract][Full Text] [Related]
6. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal choroidal thickness predicts macular atrophy in age-related macular degeneration: results from the TREX-AMD trial.
Fan W; Abdelfattah NS; Uji A; Lei J; Ip M; Sadda SR; Wykoff CC;
Graefes Arch Clin Exp Ophthalmol; 2018 Mar; 256(3):511-518. PubMed ID: 29374796
[TBL] [Abstract][Full Text] [Related]
8. 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting.
Vardarinos A; Gupta N; Janjua R; Iron A; Empeslidis T; Tsaousis KT
BMC Ophthalmol; 2017 Apr; 17(1):58. PubMed ID: 28449645
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
[TBL] [Abstract][Full Text] [Related]
10. Detection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC Study.
Do DV; Gower EW; Cassard SD; Boyer D; Bressler NM; Bressler SB; Heier JS; Jefferys JL; Singerman LJ; Solomon SD
Ophthalmology; 2012 Apr; 119(4):771-8. PubMed ID: 22297028
[TBL] [Abstract][Full Text] [Related]
11. Correlation of fundus fluorescein angiography and spectral-domain optical coherence tomography in identification of membrane subtypes in neovascular age-related macular degeneration.
Mathew R; Pefkianaki M; Kopsachilis N; Brar M; Richardson M; Sivaprasad S
Ophthalmologica; 2014; 231(3):153-9. PubMed ID: 24217293
[TBL] [Abstract][Full Text] [Related]
12. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
13. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
[TBL] [Abstract][Full Text] [Related]
14. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Epiretinal Membrane in Neovascular Age-Related Macular Degeneration Treatment: A Spectral-Domain Optical Coherence Tomography Study.
Chatziralli I; Stavrakas P; Theodossiadis G; Ananikas K; Dimitriou E; Theodossiadis P
Semin Ophthalmol; 2018; 33(5):651-656. PubMed ID: 29115893
[TBL] [Abstract][Full Text] [Related]
16. Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiography.
Petrarca R; Dugel PU; Nau J; Slakter JS; Jaffe GJ; Jackson TL
Ophthalmology; 2013 Feb; 120(2):328-33. PubMed ID: 23178157
[TBL] [Abstract][Full Text] [Related]
17. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
[TBL] [Abstract][Full Text] [Related]
18. Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration.
Hörster R; Ristau T; Sadda SR; Liakopoulos S
Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):645-52. PubMed ID: 21170547
[TBL] [Abstract][Full Text] [Related]
19. Super-dose anti-VEGF (SAVE) trial: 2.0 mg intravitreal ranibizumab for recalcitrant neovascular macular degeneration-primary end point.
Brown DM; Chen E; Mariani A; Major JC;
Ophthalmology; 2013 Feb; 120(2):349-54. PubMed ID: 23131717
[TBL] [Abstract][Full Text] [Related]
20. Changes in Neovascular Lesion Hyperreflectivity After Anti-VEGF Treatment in Age-Related Macular Degeneration: An Integrated Multimodal Imaging Analysis.
Casalino G; Bandello F; Chakravarthy U
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT288-98. PubMed ID: 27409485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
